Enter your email address
Submit
Write your message
1- Zoology Department, Faculty of Science, Al-Azhar University, Assiut Branch, Egypt.
2- Zoology Department, Faculty of Science, Al-Azhar University Assiut Branch, Egypt. ,m_taha@azhar.edu.eg
2- Zoology Department, Faculty of Science, Al-Azhar University Assiut Branch, Egypt. ,
Abstract: (65 Views)
Background: To investigate the effect of Ashwagandha (ASH) Withania somnifera (WS) in preventing the damage caused by Fluoxetine (FLX) on testis.
Methods: Adult thirty-two male Wistar rats were randomly divided into four groups (eight rats in each): a control group, an Ashwagandha-treated group (200 mg orally) according to Bhargavan et al (2015), a FLX -treated group (10 mg/kg orally), and a combined FLX and ASH-treated group. Hormonal profiles (testosterone, FSH, and LH) and sperm parameters (count, motility, abnormality, and semen fructose levels) were evaluated. Testicular tissues were analyzed for biochemical markers, including glutathione peroxidase (GSH), superoxide dismutase (SOD), glutathione S-transferase (GST), malondialdehyde (MDA), and nitric oxide (NO), as well as for histopathological changes.
Results: Biochemical parameters revealed tissue oxidative stress, in FLX group which was evidenced as increase in MDA, NO level and reduction in GSH, GST, SOD activities in testes which were reduced in co-treatment group. in addition, spermatogenesis was inhibited as indicated by the decrease (testosterone, LH and FSH), (sperm count, motility). Moreover, ASH treatment leads to an increase in testosterone (TS), LH, FSH levels, sperm count and motility.
Conclusion: These observations suggest that the antioxidant properties of Ashwagandha may have played a role in ameliorating the testicular toxicity induced by Fluoxetine.
Methods: Adult thirty-two male Wistar rats were randomly divided into four groups (eight rats in each): a control group, an Ashwagandha-treated group (200 mg orally) according to Bhargavan et al (2015), a FLX -treated group (10 mg/kg orally), and a combined FLX and ASH-treated group. Hormonal profiles (testosterone, FSH, and LH) and sperm parameters (count, motility, abnormality, and semen fructose levels) were evaluated. Testicular tissues were analyzed for biochemical markers, including glutathione peroxidase (GSH), superoxide dismutase (SOD), glutathione S-transferase (GST), malondialdehyde (MDA), and nitric oxide (NO), as well as for histopathological changes.
Results: Biochemical parameters revealed tissue oxidative stress, in FLX group which was evidenced as increase in MDA, NO level and reduction in GSH, GST, SOD activities in testes which were reduced in co-treatment group. in addition, spermatogenesis was inhibited as indicated by the decrease (testosterone, LH and FSH), (sperm count, motility). Moreover, ASH treatment leads to an increase in testosterone (TS), LH, FSH levels, sperm count and motility.
Conclusion: These observations suggest that the antioxidant properties of Ashwagandha may have played a role in ameliorating the testicular toxicity induced by Fluoxetine.
Keywords: Ashwagandha, adaptogen, infertility, selective serotonin reuptake inhibitors (SSRIs), fluoxetine, lipid peroxidation, oxidative stress, spermatogenesis.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
The Iranian Journal of Toxicology
Arak University of Medical Sciences in collaboration with the Iranian Society of Toxicology
Website: http://ijt.arakmu.ac.ir
Email: tox.journal@gmail.com
